These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2652313)

  • 1. Renovascular hypertension: etiology and pathophysiology.
    Pickering TG
    Semin Nucl Med; 1989 Apr; 19(2):79-88. PubMed ID: 2652313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in one-kidney, one-clip hypertension and low renin essential hypertension.
    Hall JE
    Am J Hypertens; 1991 Oct; 4(10 Pt 2):523S-533S. PubMed ID: 1741989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
    Hollenberg NK
    Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Split intrarenal hemodynamics in renovascular hypertension.
    Kimura G; London GM; Safar ME; Kuramochi M; Omae T
    Clin Invest Med; 1991 Dec; 14(6):559-65. PubMed ID: 1794208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of neurohormonal changes following the production of the benign and malignant phases of two-kidney, two-clip Goldblatt hypertension.
    Suzuki H; Saruta T; Ferrario CM; Brosnihan KB
    Jpn Heart J; 1987 May; 28(3):413-26. PubMed ID: 2887673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin-converting enzyme inhibition: direct and indirect mechanisms].
    Stumpe KO
    Klin Wochenschr; 1985 Sep; 63(18):897-906. PubMed ID: 2997540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of renal hemodynamics and glomerular filtration in patients with renovascular hypertension during converting enzyme inhibition with captopril.
    Textor SC; Tarazi RC; Novick AC; Bravo EL; Fouad FM
    Am J Med; 1984 May; 76(5B):29-37. PubMed ID: 6328984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition: renal aspect.
    Hollenberg NK
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S40-4. PubMed ID: 2580175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats.
    Cervenka L; Wang CT; Mitchell KD; Navar LG
    Hypertension; 1999 Jan; 33(1):102-7. PubMed ID: 9931089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship.
    Sealey JE; Blumenfeld JD; Bell GM; Pecker MS; Sommers SC; Laragh JH
    J Hypertens; 1988 Oct; 6(10):763-77. PubMed ID: 3058795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats.
    Oliveira-Sales EB; Varela VA; Maquigussa E; Borges FT; Shimoura CG; Gomes G; Campos RR; Boim MA
    Clin Exp Hypertens; 2016; 38(7):586-593. PubMed ID: 27649588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of intrarenal angiotensin II levels in 2 kidney 1 clip and angiotensin II induced hypertension.
    Navar LG; Von Thun AM; Zou L; el-Dahr SS; Mitchell KD
    Blood Press Suppl; 1995; 2():88-92. PubMed ID: 7582082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephron heterogeneity: clue to the pathogenesis of essential hypertension and effectiveness of angiotensin-converting enzyme inhibitor treatment.
    Laragh JH
    Am J Med; 1989 Dec; 87(6B):2S-14S. PubMed ID: 2690611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal responses to AT1 receptor blockade.
    Navar LG; Harrison-Bernard LM; Imig JD; Cervenka L; Mitchell KD
    Am J Hypertens; 2000 Jan; 13(1 Pt 2):45S-54S. PubMed ID: 10678288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dopamine in the striatum, renin-angiotensin system and renal sympathetic nerve on the development of two-kidney, one-clip Goldblatt hypertension.
    Sawamura T; Nakada T
    J Urol; 1996 Mar; 155(3):1108-11. PubMed ID: 8583574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renovascular hypertension may cause nephrotic range proteinuria and focal glomerulosclerosis in contralateral kidney.
    Ubara Y; Hara S; Katori H; Yamada A; Morii H
    Clin Nephrol; 1997 Oct; 48(4):220-3. PubMed ID: 9352155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonatherosclerotic Renovascular Hypertension.
    Dalman J; Coleman DM
    Surg Clin North Am; 2023 Aug; 103(4):733-743. PubMed ID: 37455034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.